Capital City Trust’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.92M Buy
14,692
+2
+0% +$542 0.9% 33
2025
Q4
$3.69M Sell
14,690
-157
-1% -$41.7K 0.82% 35
2025
Q3
$4.26M Sell
14,847
-555
-4% -$149K 1.04% 29
2025
Q2
$4.04M Buy
15,402
+98
+0.6% +$23.9K 1.05% 32
2025
Q1
$3.56M Sell
15,304
-249
-2% -$60.4K 0.98% 36
2024
Q4
$3.57M Buy
15,553
+223
+1% +$51.2K 0.89% 38
2024
Q3
$3.43M Buy
15,330
+89
+0.6% +$19.6K 0.85% 38
2024
Q2
$3.1M Buy
15,241
+79
+0.5% +$16.1K 0.84% 37
2024
Q1
$3.31M Sell
15,162
-409
-3% -$90.1K 0.92% 36
2023
Q4
$3.54M Sell
15,571
-40
-0.3% -$8.4K 1.05% 33
2023
Q3
$3.14M Sell
15,611
-2,472
-14% -$521K 1.04% 34
2023
Q2
$3.75M Sell
18,083
-56
-0.3% -$10.9K 1.17% 30
2023
Q1
$3.58M Sell
18,139
-36
-0.2% -$7.41K 1.14% 32
2022
Q4
$3.68M Sell
18,175
-336
-2% -$65.7K 1.21% 29
2022
Q3
$3.26M Buy
18,511
+177
+1% +$36.2K 1.14% 31
2022
Q2
$3.69M Sell
18,334
-125
-0.7% -$26.6K 1.2% 28
2022
Q1
$4.18M Buy
18,459
+194
+1% +$45.6K 1.21% 28
2021
Q4
$4.93M Buy
18,265
+223
+1% +$55.2K 1.4% 22
2021
Q3
$4.36M Sell
18,042
-87
-0.5% -$21.9K 1.35% 22
2021
Q2
$4.3M Buy
18,129
+358
+2% +$81.6K 1.3% 26
2021
Q1
$3.89M Buy
17,771
+140
+0.8% +$28.1K 1.24% 26
2020
Q4
$3.08M Sell
17,631
-55
-0.3% -$9.5K 1.08% 30
2020
Q3
$2.86M Buy
17,686
+190
+1% +$30.1K 1.05% 28
2020
Q2
$2.5M Buy
17,496
+1,675
+11% +$232K 0.96% 31
2020
Q1
$1.72K Buy
15,821
+98
+0.6% +$14.1K 0.77% 38
2019
Q4
$2.29M Buy
15,723
+30
+0.2% +$4.33K 0.86% 38
2019
Q3
$2.27M Sell
15,693
-565
-3% -$82.4K 1% 38
2019
Q2
$2.42M Buy
16,258
+7
+0% +$977 0.99% 36
2019
Q1
$2.13M Sell
16,251
-29
-0.2% -$3.57K 0.9% 39
2018
Q4
$1.77M Sell
16,280
-149
-0.9% -$20K 0.81% 39
2018
Q3
$2.45M Buy
16,429
+641
+4% +$97.5K 0.98% 37
2018
Q2
$2.44M Sell
15,788
-425
-3% -$64.2K 1.04% 35
2018
Q1
$2.25M Sell
16,213
-155
-0.9% -$22.8K 0.97% 36
2017
Q4
$2.24K Sell
16,368
-1,077
-6% -$142K 0.92% 38
2017
Q3
$2.31M Hold
17,445
0.9% 33
2017
Q2
$2.31M Sell
17,445
-1,299
-7% -$159K 0.9% 33
2017
Q1
$2.31M Sell
18,744
-761
-4% -$90.1K 0.91% 34
2016
Q4
$2.15M Sell
19,505
-3,818
-16% -$424K 0.86% 36
2016
Q3
$2.75M Sell
23,323
-394
-2% -$46.4K 1.11% 30
2016
Q2
$2.65M Sell
23,717
-226
-0.9% -$24.3K 1.07% 32
2016
Q1
$2.41M Buy
23,943
+371
+2% +$35.6K 0.97% 34
2015
Q4
$2.5M Buy
23,572
+75
+0.3% +$7.74K 1.03% 32
2015
Q3
$2.19M Buy
23,497
+2,393
+11% +$248K 0.92% 38
2015
Q2
$2.2M Sell
21,104
-152
-0.7% -$15.8K 0.89% 36
2015
Q1
$2.3M Buy
21,256
+314
+1% +$32.3K 0.93% 35
2014
Q4
$1.94M Sell
20,942
-23
-0.1% -$2.03K 0.79% 44
2014
Q3
$1.83M Buy
20,965
+752
+4% +$67.9K 0.77% 45
2014
Q2
$1.78M Buy
20,213
+169
+0.8% +$14.6K 0.74% 46
2014
Q1
$1.69M Sell
20,044
-343
-2% -$27.4K 0.73% 44
2013
Q4
$1.6M Sell
20,387
-367
-2% -$31.3K 0.69% 46
2013
Q3
$1.77K Sell
20,754
-92
-0.4% -$7.75K 0.78% 39
2013
Q2
$1.79M Buy
+20,846
New +$1.73M 0.79% 39

Other funds holding LH

Capital City Trust's LH Position: Q1 2026 in Review

Capital City Trust increased its Labcorp (LH) stake by 0.01% in Q1 2026, buying an estimated $542 and bringing the position to 14,692 shares worth $3.92M. The position accounts for 0.9% of the portfolio, ranked #33.

Capital City Trust first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.93M in Q4 2021. 1,032 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Capital City Trust held 14,692 shares of Labcorp worth $3.92M as of Q1 2026.
  • Capital City Trust bought 2 Labcorp shares in Q1 2026, an estimated $542.
  • Labcorp made up 0.9% of Capital City Trust's portfolio in Q1 2026, its #33 holding.
  • Capital City Trust first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Capital City Trust's Labcorp position peaked at $4.93M in Q4 2021.
  • 1,032 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Capital City Trust's 13F filing for Q1 2026, filed 1 May 2026.